Use of anti-inflammatory therapy and asthma mortality in Japan

European Respiratory Journal

Volumn 21, Issue 1, 2003, Pages 101-104

  Suissa, S ^a   Ernst, P ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Asthma; Epidemiological studies; Inhaled glucocorticoids; Leukotriene receptor antagonist; Mortality; Secular trends

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; CORTICOSTEROID; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG MARKETING; ECOSYSTEM; HUMAN; JAPAN; MORTALITY; POISSON DISTRIBUTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; JAPAN; LEUKOTRIENE ANTAGONISTS; STEROIDS;

EID: 0037246435     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00058503     Document Type: Article

References (16)

1. Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 1998; 101: S427-S433.
2. National Asthma Education Program National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Publication No. 91-3042. Bethesda, MD, National Institutes of Health, 1991; pp. 1-135.
3. Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990; 85: 1098-1111.
4. Blais L, Ernst P, Boivin JF, et al. Am J Respir Crit Care Med 1998; 158: 126-132.
5. Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992; 268: 3462-3464.
6. Suissa S, Ernst P, Benayoun B, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332-336.
7. Devoy MA, Fuller RW, Palmer JB. Asthma mortality and beta-agonists. Chest 1995; 108: 1768.
8. Suissa S, Ernst P. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. J Clin Epidemiol 1997; 50: 1079-1088.
9. Goldman M, Rachmiel M, Gendler L, Katz Y. Decrease in asthma mortality rate in Israel from 1991-1995: is it related to increased use of inhaled corticosteroids? J Allergy Clin Immunol 2000; 105: 71-74.
10. Lipworth BJ. Leukotriene-receptor antagonists. Lancet 1999; 353: 57-62.
11. National Asthma and Prevention Program. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. Publication No. 97-4051. Bethesda, MD, USA, National Institutes of Health, 1997.
12. Suissa S, Dennis R, Ernst P, Sheehy O, Wood-Dauphinee S. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997; 126: 177-183.
13. Generalized Linear Models. 2nd edn. London, Chapman and Hall, 1989.
14. Makino S, Miyamoto T, Nakajima S, et al. Survey of recognition and utilization of guidelines for the diagnosis and management of bronchial asthma in Japan. Allergy 2000; 55: 135-140.
15. Makino SFK, Miyamoto T, Ohta K. Asthma prevention and management guidelines. Int Arch Allergy Immunol 2000; 121: Suppl. 1.
16. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107: 937-944.